drugset / Trial / NCT00468806
Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to look at how much of a new drug, GSK598809 binds to specific proteins in the brain and how much stays in the blood over a range of different doses.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK598809 | Unknown | — | Oral |
Indications
No indication recorded.